Stay updated on ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial
Sign up to get notified when there's something new on the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page.

Latest updates to the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe page now shows Revision: v3.4.2; the earlier funding-status notice (Revision: v3.4.1) has been removed. There are no changes to study details or eligibility information.SummaryDifference0.5%

- Check21 days agoChange DetectedA site-wide funding notice is added and the version updated from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedGlossary display has been added. Metadata labels have been updated to Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, replacing the previous v3.3.4 text.SummaryDifference0.2%

- Check42 days agoChange DetectedRevision tag updated from v3.3.3 to v3.3.4. No study details or user-facing content were changed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded a Locations section listing Victoria as a study site and updated the page revision to v3.3.3; the HHS Vulnerability Disclosure and the previous Victoria Locations entry (v3.3.2) were removed from the footer.SummaryDifference0.2%

- Check85 days agoChange DetectedThe page revision label updated from v3.3.1 to v3.3.2. This is a minor metadata update with no changes to study content, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ICV Valproate Dose Ranging in Temporal Seizures Clinical Trial page.